Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

What the Market Looks Like?

The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. North America accounted for the largest market share, followed by Europe.

According to market research analysts, the Anatomic Pathology market is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecast period. Reports provide insights regarding the lucrative market opportunities within the Anatomic Pathology Market at the country level. Furthermore, the report outlines a detailed cost, segment, trend, region, and commercial development of the major leading players globally for the forecast period.

The growth in this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent during the forecast period.

Read More in Detailed (Anatomic Pathology Market) @ https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology...

Anatomic Pathology Services segment accounted for the largest share of the global anatomic pathology market in 2020.

Based on product & service, the anatomic pathology market is segmented into services, consumables, and instruments. The services segment accounted for the largest market share in 2020. The large share of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.

By Application, disease diagnostics accounted for the largest market share in 2020

Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment accounted for a larger share of the market in 2020 due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.

By End User, Hospital laboratories accounted for the largest market share in 2020

Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. Hospital laboratories accounted for the largest share in 2020. The large share of this segment can be attributed to the increasing number of patient visits to hospitals, the growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

North America dominates the anatomic pathology market

The global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the anatomic pathology market. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.

The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan).

Make an Enquire to Buy this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1...

Recent Developments:

In May 2021, Hologic received premarket approval (PMA) from the FDA for its ThinPrep GenesisTM processor for cytology processing and specimen transfer for downstream applications.
In January 2019, PHC Holding Corporation completed the acquisition of Thermo Fisher Scientific’s Anatomical Pathology business to strengthen its position in the diagnostics segment.

Frequently Asked Questions (FAQ):

What is the projected market value of the global anatomic pathology market?
What is the estimated growth rate (CAGR) of the global anatomic pathology market for the next five years?
Who are the major players offering anatomic pathology in the market?
Which end user segment of the global anatomic pathology market is expected to witness the highest growth?
Which product and service segment is expected to have the largest market share during the forecast period?